A Study to Assess Bioavailability & Food Effect of Different Liquid and Capsule Formulations of TMC435.

NCT01571570 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: TMC435 150 mg capsule
DRUG: TMC435 150 mg oral suspension (20 mg/mL)
DRUG: TMC435 150 mg oral solution (10 mg/mL)
DRUG: TMC435 150 mg capsule concept K
DRUG: TMC435 150 mg capsule concept L

Sponsor

Janssen R&D Ireland